This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
You’ve read about the top 10 molecules with publications from July, but what about the ones we found interesting that…
Article
1 year ago ●
8 mins read
A Treg-modulating IKZF2 (Helios) glue degrader for cancer immunotherapy. Tumors can evade the immune system through the recruitment of regulatory…
molecule
5 months ago ●
7 mins read
This article is Part VI of a review series covering all the initial public offerings for the biotech and pharmaceutical…
Article
1 year ago ●
7 mins read
ACT-777991: next-generation CXCR3 antagonist in Phase I trials for Type 1 diabetes. ACT-777991, an oral and insurmountable CXCR3 antagonist discovered…
molecule
5 months ago ●
11 mins read
This edition of Drug Hunter Letters highlights recent insightful communications from Drug Hunter readers, including: Simon Bury on the History…
Article
1 year ago ●
7 mins read
MC4R antagonism to help gain weight. PF-07258669 is a melanocortin-4 receptor (MC4R) antagonist intended to help increase weight gain, in…
molecule
6 months ago ●
6 mins read
Load More
